SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005807
Filing Date
2021-05-05
Accepted
2021-05-05 08:00:37
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pasg-20210331x10q.htm 10-Q 1350936
2 EX-10.1 pasg-20210331ex10107021e.htm EX-10.1 80660
3 EX-31.1 pasg-20210331ex3113e0655.htm EX-31.1 10888
4 EX-31.2 pasg-20210331ex31232153a.htm EX-31.2 10735
5 EX-32.1 pasg-20210331ex321f97401.htm EX-32.1 5973
6 EX-32.2 pasg-20210331ex3229447ed.htm EX-32.2 5953
7 GRAPHIC pasg-20210331x10q001.jpg GRAPHIC 51413
  Complete submission text file 0001558370-21-005807.txt   5523252

Data Files

Seq Description Document Type Size
8 EX-101.INS pasg-20210331.xml EX-101.INS 1221466
9 EX-101.SCH pasg-20210331.xsd EX-101.SCH 38663
10 EX-101.CAL pasg-20210331_cal.xml EX-101.CAL 37071
11 EX-101.DEF pasg-20210331_def.xml EX-101.DEF 111141
12 EX-101.LAB pasg-20210331_lab.xml EX-101.LAB 357498
13 EX-101.PRE pasg-20210331_pre.xml EX-101.PRE 250731
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39231 | Film No.: 21891234
SIC: 2836 Biological Products, (No Diagnostic Substances)